Histopathological Classification of Pseudomyxoma Peritonei and the Prognostic Importance of PINCH Protein

  1. HAILE MAHTEME1
  1. 1Department of Surgical Sciences, Section of Surgery, Uppsala University, Uppsala, Sweden
  2. 2Department of Immunology, Genetics and Pathology, Section of Oncology, Uppsala University, Uppsala, Sweden
  3. 3Department of Oncology, Institute of Clinical and Experimental Medicine, University of Linköping, Linköping, Sweden
  4. 4Department of Radiology, Oncology and Radiation Science, Section of Oncology, Uppsala University, Uppsala, Sweden
  5. 5Department of Oncology and Pathology, Radiumhemmet, Karolinska Institute, Stockholm, Sweden
  6. 6Department of Pathology, Tangshan Gongren Hospital, Tangshan, P.R. China
  1. Correspondence to: Haile Mahteme, MD, Ph.D., Department of Surgery, Uppsala University Hospital, S-751 85 Uppsala, Sweden. Tele: +46 186114613, Fax: +46 18504414, e-mail: Haile.Mahteme{at}surgsci.uu.se

Abstract

Aim: The aims of this study were i) to assess a new and more detailed histopathological classification and to analyze concordance between pathologists in the histopathological classification of pseudomyxoma peritonei (PMP); ii) to analyze the expression in the stroma of the particularly interesting new cysteine-histidine (PINCH) protein and its prognostic importance in PMP. Materials and Methods: Surgical specimens from 81 patients, classified according to the Ronnett et al histopathological classification were compared to a new system with four groups ranging from indolent to aggressive growth patterns. PINCH protein expression was analyzed and was related to clinical variables. Results: The new four-group classification provided better prognostic information than the classification according to Ronnett et al. (p=0.04). Expression of the PINCH protein in the stroma was found in 83% of the cases and was associated with high tumor burden (p=0.002) and a poor prognosis (p=0.04). Conclusion: The proposed new PMP classification system may provide additional prognostic information. PINCH protein is expressed in PMP and has prognostic information.

  • Received February 10, 2012.
  • Revision received March 8, 2012.
  • Accepted March 9, 2012.
| Table of Contents